Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Treatment of AML with Azacytidine (AZA): Current Results of the French ATU Program.

Blood (2007) 110 (11): 1849.

https://doi.org/10.1182/blood.V110.11.1849.1849

Published: 2007

Journal Articles

Treatment of High Risk MDS and AML Post-MDS with Azacytidine (AZA): Preliminary Results of the French ATU Program.

Claire Fabre, MD, Fatsiha Chermat, Laurence Legros, MD, Sophie Park, MD, François Dreyfus, MD, Françoise Isnard, MD, Florence Nowak, MD, Anne Marfaing, MD, Stéphane de Botton, MD, Marie-Pierre Noel, MD, Christophe Fruchart, MD, Thomas Prebet, MD, Norbert Vey, MD, Caroline Dartigeas, MD, Pierre Fenaux, MD PhD

Blood (2006) 108 (11): 2664.

https://doi.org/10.1182/blood.V108.11.2664.2664

Published: 2006

Journal Articles

Treatment of Myelodysplastic Syndromes with del 5q before the Lenalidomide Era: The GFM Experience.

Charikleia Kelaidi, MD, Sophie Park, MD, Sabine Brechignac, MD, Lionel Mannone, MD, Norbert Vey, MD, Herve Dombret, MD, Lina Aljassem, MD, Aspasia Stamatoullas, MD, Lionel Adès, MD, Stéphane Giraudier, MD, Stéphane de Botton, MD, Béatrice Mahé, MD, Pascale Lepelley, MD, Françoise Picard, MD, Geneviève Leroux, MD, Marie-Thérèse Daniel, MD, Didier Bouscary, MD, François Dreyfus, MD, Pierre Fenaux, MD

Blood (2006) 108 (11): 2678.

https://doi.org/10.1182/blood.V108.11.2678.2678

Published: 2006

Journal Articles

Rescue of early-stage myelodysplastic syndrome-deriving erythroid precursors by the ectopic expression of a dominant-negative form of FADD

Yann-Erick Claessens, Sophie Park, Anne Dubart-Kupperschmitt, Virginie Mariot, Carmen Garrido, Stany Chrétien, François Dreyfus, Catherine Lacombe, Patrick Mayeux, Michaëla Fontenay

Blood (2005) 105 (10): 4035–4042.

https://doi.org/10.1182/blood-2004-08-3166

Published: 2005

Journal Articles

Health, economic, and quality-of-life effects of erythropoietin and granulocyte colony-stimulating factor for the treatment of myelodysplastic syndromes: a randomized, controlled trial

Blood (2004) 104 (2): 321–327.

https://doi.org/10.1182/blood-2003-07-2252

Published: 2004

Journal Articles

In vitro proliferation and differentiation of erythroid progenitors from patients with myelodysplastic syndromes: evidence for Fas-dependent apoptosis

Yann-Erick Claessens, Didier Bouscary, Jean-Michel Dupont, Françoise Picard, Josiane Melle, Sylvie Gisselbrecht, Catherine Lacombe, François Dreyfus, Patrick Mayeux, Michaëla Fontenay-Roupie

Blood (2002) 99 (5): 1594–1601.

https://doi.org/10.1182/blood.V99.5.1594

Published: 2002

Journal Articles

High-Dose Therapy and Autologous Peripheral Blood Stem Cell Transplantation in Multiple Myeloma: Up-front or Rescue Treatment? Results of a Multicenter Sequential Randomized Clinical Trial

Jean-Paul Fermand, Philippe Ravaud, Sylvie Chevret, Marine Divine, Véronique Leblond, Coralie Belanger, Margaret Macro, Edouard Pertuiset, François Dreyfus, Xavier Mariette, Catherine Boccacio, Jean-Claude Brouet

Blood (1998) 92 (9): 3131–3136.

https://doi.org/10.1182/blood.V92.9.3131

Published: 1998

Journal Articles

Antileukemic HLA-Restricted T-Cell Clones Generated With Naturally Processed Peptides Eluted From Acute Myeloblastic Leukemia Blasts

Marina Ostankovitch, Agnès Buzyn, Delphine Bonhomme, Francine Connan, Didier Bouscary, Fahrad Heshmati, François Dreyfus, Jeannine Choppin, Jean-Gérard Guillet

Blood (1998) 92 (1): 19–24.

https://doi.org/10.1182/blood.V92.1.19.413a40_19_24

Published: 1998

NARROW

Treatment of AML with Azacytidine (AZA): Current Results of the French ATU Program.

Treatment of High Risk MDS and AML Post-MDS with Azacytidine (AZA): Preliminary Results of the French ATU Program.

Treatment of Myelodysplastic Syndromes with del 5q before the Lenalidomide Era: The GFM Experience.

Rescue of early-stage myelodysplastic syndrome-deriving erythroid precursors by the ectopic expression of a dominant-negative form of FADD

Health, economic, and quality-of-life effects of erythropoietin and granulocyte colony-stimulating factor for the treatment of myelodysplastic syndromes: a randomized, controlled trial

In vitro proliferation and differentiation of erythroid progenitors from patients with myelodysplastic syndromes: evidence for Fas-dependent apoptosis

High-Dose Therapy and Autologous Peripheral Blood Stem Cell Transplantation in Multiple Myeloma: Up-front or Rescue Treatment? Results of a Multicenter Sequential Randomized Clinical Trial

Antileukemic HLA-Restricted T-Cell Clones Generated With Naturally Processed Peptides Eluted From Acute Myeloblastic Leukemia Blasts

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only